Cargando…
Ciclesonide uptake and metabolism in human alveolar type II epithelial cells (A549)
BACKGROUND: Ciclesonide is a novel inhaled corticosteroid for the treatment of airway inflammation. In this study we investigated uptake and in vitro metabolism of ciclesonide in human alveolar type II epithelial cells (A549). Ciclesonide uptake was compared with fluticasone propionate, an inhaled c...
Autores principales: | Nonaka, Takashi, Nave, Rüdiger, McCracken, Nigel, Kawashimo, Atsuko, Katsuura, Yasuhiro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central|1
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048954/ https://www.ncbi.nlm.nih.gov/pubmed/17900334 http://dx.doi.org/10.1186/1471-2210-7-12 |
Ejemplares similares
-
Metabolism of ciclesonide in the upper and lower airways: review of available data
por: Nave, Ruediger, et al.
Publicado: (2008) -
Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa
por: Sato, Hideyuki, et al.
Publicado: (2007) -
In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices
por: Nave, Ruediger, et al.
Publicado: (2007) -
From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids
por: Nave, Ruediger, et al.
Publicado: (2013) -
Ciclesonide for the treatment of asthma
por: Dahl, Ronald
Publicado: (2006)